PubMed ID: 41934447 Author(s): Kopplin LJ, Armbrust KR. Re: Ghoraba et al.: Incidence of endophthalmitis after cataract surgery in the setting of uveitis and immunosuppressive therapy within the IRIS(R) Registry (Ophthalmology. 2025;132:1253-1259). Ophthalmology. 2026 Apr …
Laura Kopplin
Impact of Socioeconomic Disadvantage on Clinical Outcomes of Inflammatory Eye Disease Patients Requiring Systemic Immunosuppression.
PubMed ID: 41697837 Author(s): Trudrung MA, Peterson KD, Kopplin LJ. Impact of Socioeconomic Disadvantage on Clinical Outcomes of Inflammatory Eye Disease Patients Requiring Systemic Immunosuppression. Ocul Immunol Inflamm. 2026 Feb 16:1-6. doi: 10.1080/09273948.2026.2631079. Online ahead …
Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern®.
PubMed ID: 41670577 Author(s): Wallace DK, Flaxel CJ, Gedde SJ, Jacobs DS, Kopplin LJ, Lee BS, Mah FS, Oetting TA, Varu DM, Musch DC. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern(R). Ophthalmology. 2026 Feb …
Update on Therapy for Non-Infectious Scleritis.
PubMed ID: 41937961 Author(s): Richey A, Sattarova V, Kopplin LJ, Armbrust KR. Update on Therapy for Non-Infectious Scleritis. Clin Ophthalmol. 2026 Mar 30;20:563490. doi: 10.2147/OPTH.S563490. eCollection 2026. PMID 41937961 Journal: Clinical Ophthalmology (Auckland, N.Z.), Volume …
Evaluating the Effectiveness of Escalating to Weekly Adalimumab Dosing for the Treatment of Non-infectious Uveitis: A Multi-Center Study.
PubMed ID: 41038454 Author(s): Pillar S, Thomas A, Hassman L, Chen H, Gangaputra S, Kopplin LJ, Boyd K, Moussa K, Pham DC, Tsui E. Evaluating the Effectiveness of Escalating to Weekly Adalimumab Dosing for the …
Cataract Surgery in Patients With Scleritis in the United States: An IRIS Registry (Intelligent Research in Sight) Analysis.
PubMed ID: 40801671 Author(s): Armbrust KR, Kopplin LJ. Cataract Surgery in Patients With Scleritis in the United States: An IRIS Registry (Intelligent Research in Sight) Analysis. Cornea. 2025 Aug 13. doi: 10.1097/ICO.0000000000003949. Online ahead of …
THE HETEROGENEOUS PRESENTATIONS OF DE NOVO AND RECURRENT OCULAR INFLAMMATION AFTER COVID-19 VACCINATION : A Multicenter Report and a Review of the Literature
PubMed ID: 39841907 Author(s): Arepalli S, Kopplin L, Tsui E, Brill D, Sobrin L, Papaliodis G, Darwish D, Raiji V, Janardhana P, Emami-Naeini P, Nore L, Parker M, Thomas AS. THE HETEROGENEOUS PRESENTATIONS OF DE …
Prevalence, Treatment Patterns, and Outcomes of Pediatric Non-Infectious Uveitis in the United States: An IRIS® Registry Analysis.
PubMed ID: 40349981 Author(s): Uner OE, Lin P, Kopplin LJ, Lum F, Liu L, Li C, Arepalli S, Goldstein D, Rosenbaum JT, Suhler EB, Thomas AS. Prevalence, Treatment Patterns, and Outcomes of Pediatric Non-Infectious Uveitis …
CLARITY
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis